AVICEDA THERAPEUTICS
Live / Registered — Registered (as of 16 Jun 2020)
What this means for you
Registered since 16 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88474036
- Registration number
- 6081670
- Mark type
- Design + words
- Filed
- 14 Jun 2019
- Published for opposition
- 15 Oct 2019
- Registered
- 16 Jun 2020
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 042 — Scientific and technological services: Research and development in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; clinical trials in the fields of ocular degenerative, inflammatory, allergic, diabetic retinopathy, macular degeneration, and fibrotic diseases; providing a website with information on medical research in the fields of ocular degenerative, inflammatory, and fibrotic diseases via the Internet
Owner
- Aviceda Therapeutics Inc., Cambridge, MA, US
- Aviceda Therapeutics Inc., Cambridge, MA, US
- Aviceda Therapeutics Inc., Cambridge, MA, US
Prosecution history
- 16 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 12 May 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Apr 2020 — USE AMENDMENT FILED
- 30 Apr 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Apr 2020 — TEAS STATEMENT OF USE RECEIVED
- 10 Dec 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Oct 2019 — PUBLISHED FOR OPPOSITION
- 25 Sept 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED